The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel liquid biopsy assay with an 88% detection rate of genomic alterations across CNS tumors.
 
Matthew Gordon Varga
Employment - BillionToOne
 
Christian Klosowski
Employment - BillionToOne
Stock and Other Ownership Interests - BillionToOne
Consulting or Advisory Role - BillionToOne
 
Xavier Bower
Employment - BillionToOne
Stock and Other Ownership Interests - BillionToOne; Others; Vertex
Research Funding - BillionToOne
Patents, Royalties, Other Intellectual Property - Author on provisional patent
 
David Tsao
Employment - BillionToOne, Inc.
Leadership - BillionToOne, Inc.
Stock and Other Ownership Interests - BillionToOne
Consulting or Advisory Role - Horizon Surgical Systems. Inc. (I)
Patents, Royalties, Other Intellectual Property - Multiple patents related to molecular diagnostics techniques, especially with applications in cell-free DNA, non-invasive prenatal testing, and liquid biopsy.
Travel, Accommodations, Expenses - BillionToOne, Inc
 
Gary A. Palmer
Employment - BillionToOne
Leadership - BillionToOne
Stock and Other Ownership Interests - BillionToOne
 
Santosh Kesari
Stock and Other Ownership Interests - Curtana; Praesidia; xcures
Honoraria - Jubilant Biosys; Pyramid Biosciences
Consulting or Advisory Role - biocept; iCAD; xcures
Research Funding - AIVITA Biomedical, Inc. (Inst); Bayer (Inst); Biocept (Inst); Blue Earth Diagnostics (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Caris MPI (Inst); cns pharmaceuticals (Inst); EpicentRx (Inst); Lilly (Inst); Oblato (Inst); Orbus therapeutics (Inst)